Today, those interested in maintaining healthy blood sugar glucose levels still have limited choices when it comes to good tasting, thirst quenching Beverages. GlucoDown® manufactured by publicly traded Glucose Health, Inc. Trading under the symbol G-L-U-C is expanding consumer choice for blood sugar friendly beverages. A leader in America’s true growth industry – Diabetes friendly functional beverages. GlucoDown’s prebiotic fiber blocks the body's absorption of dietary sugars, moderates after-meal increases in glucose levels and helps maintain regular digestive health. Every nutritious and delicious serving has no sugar, no caffeine, and is a great source of prebiotic soluble fiber. All 8 flavors are dietitian recommended to maintain blood sugar in a healthy range – especially after meals. Available at CVS, Publix, online at Walmart dot com and a top category choice on Amazon. GlucoDown is available nationwide. GlucoDown® is a proprietary beverage formula, including a unique form of soluble fiber, targeted vitamins and minerals, and an extract of the Banaba Leaf plant, developed by Glucose Health, Inc. and Chandrasekhar Mallangi, Ph.D. The beverage was initially formulated to be a nutraceutical drink for pre-diabetic and diabetic persons and was named Glucose Health. In 2018, Glucose Health Inc. improved upon the formula and successfully launched the first soluble fiber infused iced tea mixes in North American under the GlucoDown® brand. The flavors launched include Peach Tea, Lemon Tea, Raspberry Tea and Super Berry Tea (a combination of blueberry and blackberry). In January 2021, the Company launched four new drink (not tea based) mixes also under the GlucoDown® brand. The flavors launched include Watermelon, Cherry, Peach Mango and Strawberry Banana. Glucose Health, Inc. is presently developing additional flavors for the GlucoDown® brand including coffees and the Company is launching its second soluble fiber infused brand, FIBER UP®.
Outstanding Shares 16,681,965 Restricted 6,701,959 Unrestricted 9,980,006 Held at DTC / Float 7,925,984
Glucose Health, Inc. manufactures nutritional beverages for the diabetic-adult nutrition retail category. The Centers for Disease Control & Prevention today estimates 100 million Americans are pre-diabetic or Type-2 diabetic. GLUCODOWN is the first diabetic friendly beverage manufactured in North America enriched with a special form of soluble fiber clinically shown to help maintain healthy blood sugar and cholesterol levels. GLUCODOWN offer consumers a nutritious, functional beverage choice and is available in eight delicious flavors. GLUCODOWN is available in-store at pharmacies in all 50 States and online at Amazon (search GLUCODOWN)
The Product
Make the commitment to a better future by living healthier today with GlucoDown®. A daily commitment to even a modestly more active lifestyle, better nutrition and normal body weight and composition, is key to maintaining healthy blood sugar, triglycerides, cholesterol and regular digestive health. The special soluble fiber in the GlucoDown® formula may help slow your body's absorption of dietary sugars; moderate after- meal increases in glucose levels and maintain regular digestive health.
The GLUC Report : Company information on Glucose Health Inc. (OTC: GLUC)
Nationally Aired TV Commercial
In The News
The Brand
IMPORTANT CORPORATE DEVELOPMENTS - GLUCOSE HEALTH, INC. (OTC: GLUC) Press Release | 11/03/2022 Three outstanding candidates have now accepted nominations to serve as independent directors of the Company. Charters for the enactment of Audit, Compensation and Corporate Governance/Nominations committees, each comprised, or majority comprised, of the independent directors, have been established. The Company appointed a Public Company Accounting Oversight Board (PCAOB) firm as auditor. Audit of fiscal years 2020 and 2021, and interim reviews of the first two quarterly periods of fiscal 2022, have been completed. A Certified Public Accountant (CPA) with a decade of public company accounting and audit preparatory experience has now agreed to be appointed to a newly created officer position, Chief Accounting Officer. Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022 Press Release | 10/24/2022 Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal 2022, for the period ended September 30, 2022 Q3 2022 Revenue of $340,681 vs. $234,930 for Q3 2021 = a 45% increase. Q3 2022 Gross Profit of $153,789 vs. $62,032 for Q3 2021 = a 148% increase. Q3 2022 Net Income of $8,091 vs. Q3 2021 Net Loss of $133,160.